Advanced search
Publication Cover
The Aging Male Volume 18, 2015 - Issue 4
Submit an article Journal homepage
805
Views
10
CrossRef citations to date
0
Altmetric
Original Article

Efficacy of 5α-reductase inhibitors for patients with large benign prostatic hyperplasia (>80 mL) after transurethral resection of the prostate

Xiaoqiang QianDepartment of Urology, Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, P.R. China,
,
Guopeng YuDepartment of Urology, Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, P.R. China,
,
Yu QianDepartment of Urology, Kongjiang Hospital, Shanghai, P.R. China,
,
Ding XuDepartment of Urology, Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, P.R. China,
,
Hailong LiuDepartment of Urology, Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, P.R. China,
,
Xiangjie KongDepartment of Urology, Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, P.R. China,
,
Yunkai ZhuDepartment of Ultrasound in Medicine, Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, P.R. China,
,
Zhong WangDepartment of Urology, Ninth Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, P.R. China, and
,
Junhua ZhengDepartment of Urology, Tenth Hospital Affiliated to Shanghai Tongji University School of Medicine, Shanghai, P.R. China
&
Jun QiDepartment of Urology, Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, P.R. China, Correspondence[email protected]
 show all
Pages 238-243 | Received 08 Apr 2015, Accepted 30 Jun 2015, Published online: 30 Jul 2015

References

  • Berry SJ, Isaacs JT. Comparative aspects of prostatic growth and androgen metabolism with aging in the dog versus the rat. Endocrinology 1984;114:511–20
  • Berry SJ, Coffey DS, Walsh PC, et al. The development of human benign prostatic hyperplasia with age. J Urol 1984;132:474–9
  • Yucel M, Aras B, Yalcinkaya S, et al. Conventional monopolar transurethral resection of prostate in patients with large prostate (≥80 grams). Cent Eur J Urol 2013;66:303–8
  • Persu C, Georgescu D, Arabagiu I, et al. TURP for BPH. How large is too large? J Med Life 2010;3:376–80
  • Chen Q, Zhang L, Liu YJ, et al. Bipolar transurethral resection in saline system versus traditional monopolar resection system in treating large-volume benign prostatic hyperplasia. Urol Int 2009;83:55–9
  • Muzzonigro G, Milanese G, Minardi D, et al. Safety and efficacy of transurethral resection of prostate glands up to 60 ml: a prospective comparative study with 1 year of followup. J Urol 2004;172:611–15
  • Gupta NP, Nayyar R. Management of large prostatic adenoma: lasers versus bipolar transurethral resection of prostate. Indian J Urol 2013;29:225–35
  • Tasci AI, Tugcu V, Sahin S, et al. Rapid communication: photoselective vaporization of the prostate versus transurethral resection of the prostate for the large prostate: a prospective nonrandomized bicenter trial with 2-year follow-up. J Endourol 2008;22:347–53
  • Alivizatos G, Skolarikos A, Chalikopoulos D, et al. Transurethral photoselective vaporization versus transvesical open enucleation for prostatic adenomas >80 ml: 12-mo results of a randomized prospective study. Eur Urol 2008;54:427–37
  • Krambeck AE, Handa SE, Lingeman JE. Holmium laser enucleation of the prostate for prostates larger than 175 grams. J Endourol 2010;24:433–7
  • Naspro R, Suardi N, Salonia A, et al. Holmium laser enucleation of the prostate versus open prostatectomy for prostates >70 g: 24-month follow-up. Eur Urol 2006;50:563–8
  • Wei H, Shao Y, Sun F, et al. Thulium laser resection versus plasmakinetic resection of prostates larger than 80 ml. World J Urol 2014;32:1077–85
  • Long Z, Zhang YC, He LY, et al. Comparison of transurethral plasmakinetic and transvesical prostatectomy in treatment of 100–149 mL benign prostatic hyperplasia. Asian J Surg 2014;37:58–64
  • McConnell JD, Wilson JD, George FW, et al. Finasteride, an inhibitor of 5 alpha-reductase, suppresses prostatic dihydrotestosterone in men with benign prostatic hyperplasia. J Clin Endocrinol Metab 1992;74:505–8
  • Rassweiler J, Teber D, Kuntz R, Hofmann R. Complications of transurethral resection of the prostate (TURP) – incidence, management, and prevention. Eur Urol 2006;50:969–79
  • C Persu, D Georgescu, I Arabagiu, et al. TURP for BPH. How large is too large? J Med Life 2010;3:376–80
  • Yucel M, Aras B, Yalcinkaya S, et al. Conventional monopolar transurethral resection of prostate in patients with large prostate (≥80 grams). Cent European J Urol 2013;66:303–8
  • Michielsen DP, Coomans D, Peeters I, et al. Conventional monopolar resection or bipolar resection in saline for the management of large (>60 g) benign prostatic hyperplasia: an evaluation of morbidity. Minim Invasive Ther Allied Technol 2010;19:207–13
  • Han HH, Ko WJ, Yoo TK, et al. Factors associated with continuing medical therapy after transurethral resection of prostate. Urology 2014;84:675–80
  • Bartsch G, Rittmaster RS, Klocker H. Dihydrotestosterone and the concept of alpha reductase inhibition in human benign prostatic hyperplasia. Eur Urol 2000;37:367–80
  • Feneley MR, Span PN, Schalken JA, et al. A prospective randomized trial evaluating tissue effects of finasteride therapy in benign prostatic hyperplasia. Prostatic Cancer Prostatic Dis 1999;2:277–81
  • Kavanagh LE, Jack GS, Lawrentschuk N. Prevention and management of TURP-related hemorrhage. Nat Rev Urol 2011;8:504–14
  • Hagerty JA, Ginsberg PC, Harmon JD, et al. Pretreatment with finasteride decreases perioperative bleeding associated with transurethral resection of the prostate. Urology 2000;55:684–9
  • Zaitsu M, Tonooka A, Mikami K, et al. A dual 5α-reductase inhibitor dutasteride caused reductions in vascular density and area in benign prostatic hyperplasia. ISRN Urol 2013;2013:863489
  • Nickel JC. Comparison of clinical trials with finasteride and dutasteride. Rev Urol 2004;6:S31–9
  • Claus GR. 5α-Reductase inhibition in the treatment of LUTS and BPH: update and importance of dual inhibition of types 1 and 2. Rev Urol 2004;6:S1–2

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.